Private Payer Coverage Policies for Whole Exome Sequencing (WES) in Pediatric Patients: Trends Over Time and Analysis of Evidence Cited

PURPOSE: Whole Exome Sequencing (WES) is being adopted for neurodevelopmental disorders in pediatric patients. However, little is known about current coverage policies or the evidence cited supporting these policies. Our study is the first in-depth review of private payer WES coverage policies for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Douglas, Michael P., Parker, Stephanie L., Trosman, Julia R., Slavotinek, Anne M., Phillips, Kathryn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329652/
https://www.ncbi.nlm.nih.gov/pubmed/29997388
http://dx.doi.org/10.1038/s41436-018-0043-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329652/
https://www.ncbi.nlm.nih.gov/pubmed/29997388
http://dx.doi.org/10.1038/s41436-018-0043-3

Ejemplares similares